Skip to content

In the Chinese zodiac, snakes are intelligent, strategic, and adaptable. They are even-tempered, showing a cool and calm exterior accompanied by bursts of energy and passion. Investors in Chinese equities may need all these qualities when navigating what is expected to be a challenging year ahead.

The year of the snake began nine days after Donald Trump’s inauguration as the 47th president of the United States. Investors in Chinese equities are braced for the impact of tariff hikes, which risk negatively impacting exporters, who benefited from robust demand in 2024. There is also the risk of a further tightening of restrictions on access to artificial intelligence chips.

From a Chinese policy perspective, the bigger the tariff hikes, the bigger the monetary and fiscal policy response is likely to be.

Exhibit 1: MSCI China Index

Source: Bloomberg. As of January 23, 2025. The MSCI China Index captures large- and mid-cap representation across China A shares, H shares, B shares, Red chips, P chips and foreign listings (e.g. ADRs). Past performance is not an indicator or a guarantee of future performance. Indexes are unmanaged and one cannot invest directly in an index. Important data provider notices and terms are available at www.franklintempletondatasources.com.

In contrast to President Trump’s first term in office, the Chinese government is better prepared to proactively and flexibly respond. US economic nationalism will likely be matched by Chinese fiscal and monetary policy support to strategic industries as the economy continues to close the technological gap with the United States.

The Chinese yuan is likely to weaken to support exporters, but we expect the depreciation will be controlled with no significant surprises in its daily fixing against the US dollar. Bond yields have already declined, reflecting market expectations of interest-rate cuts to ease the debt servicing burden on households and local governments.

Investors and policymakers alike understand the challenges facing the Chinese economy well. A stepped-up policy response is likely in the year ahead to ensure external policies to contain China’s development do not compound its internal challenges. In our view, this creates opportunities for investors who are prepared to be patient, taking a long-term view.

In addition to coordinating an effective monetary and fiscal response to President Trump’s tariffs, Chinese policymakers in the year of the snake will continue to grapple with the Three Ds: debt, deflation and demographics.

Investors recognize the policy challenges created by the Three Ds, and equity market valuations reflect them as well. It is important to frame these challenges with thematic growth opportunities, which include companies that offer attractive shareholder return policies and elevated dividend yields; global leaders in sustainability solutions trading at a discount to intrinsic value; and companies serving domestic consumption, which is likely to benefit from targeted stimulus measures.

Thematic Growth Opportunities in China during the Year of the Snake

Domestic consumption

Sustainability solutions including electrical mobility and renewable energy

Prioritization of shareholder return and rising dividends

The year of the snake will feature the third session of the National People’s Congress (NPC) on March 5, 2025, also known as the “Two Sessions.” The event is expected to shape the country's economic policies and growth targets for the coming year. It is possible that there will be a significant stimulus announcement at this meeting if President Trump’s tariff announcement has a greater-than-expected impact on the growth outlook.

Chinese companies with progressive shareholder return policies and high dividend yields remain a key attraction for investors, in our view, particularly given the decline in bond yields, which makes the equity dividend yield increasingly attractive. Low valuations also create a sufficient margin of safety for investors.

Increasing the return of capital to shareholders indicates to us that companies are trying to strike a balance between growth and shareholder returns. It is a recognition that growth has slowed as well as a response to demands for improved corporate governance and regulatory pressure for listed companies to increase payouts. Nevertheless, selected sectors, including consumer discretionary, are still growing and investing at a steady clip and have the balance sheet flexibility to increase capital returns.

China continues to be a leader in sustainable solutions, including the electrification of transportation and the decarbonization of the electricity grid via wind and solar energy. Its market share in electric vehicles in Europe and emerging markets is estimated to be 25% and 15% respectively.1 In Europe, technology transfer via building auto factories in the region is likely to be the price to keep European markets open for auto exports. In emerging markets, the low cost of Chinese electric vehicles is a key attraction which is likely to support demand.

The NPC may announce an upward revision to the government’s fiscal deficit, creating room for increased stimulus. This could finance targeted measures to boost household consumption, focusing on white goods and auto trade-in subsidies as well as consumption vouchers during major holidays.

The year of the snake is likely to be a volatile one for Chinese equity investors. Initially, it will be dominated by President Trump’s tariffs and his willingness to do a deal with President Xi Jinping, whom he holds in high regard.

The Three Ds: Debt, deflation and demographics remain structural challenges for the Chinese economy. Nevertheless, we are focusing on structural thematic opportunities to generate returns in the year of the snake. These include companies with progressive shareholder return policies and elevated dividend yields, global leaders in sustainability solutions and companies with exposure to domestic consumption.



IMPORTANT LEGAL INFORMATION

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. This material may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance. All investments involve risks, including possible loss of principal.

Any research and analysis contained in this material has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Data from third party sources may have been used in the preparation of this material and Franklin Templeton ("FT") has not independently verified, validated or audited such data.  Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. The mention of any individual securities should neither constitute nor be construed as a recommendation to purchase, hold or sell any securities, and the information provided regarding such individual securities (if any) is not a sufficient basis upon which to make an investment decision. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user.

Franklin Templeton has environmental, social and governance (ESG) capabilities; however, not all strategies or products for a strategy consider “ESG” as part of their investment process.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

Issued in the U.S. by Franklin Templeton, One Franklin Parkway, San Mateo, California 94403-1906, (800) DIAL BEN/342-5236, franklintempleton.com. Investments are not FDIC insured; may lose value; and are not bank guaranteed.

You need Adobe Acrobat Reader to view and print PDF documents. Download a free version from Adobe's website.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.